No Relevant Pharmacokinetic (PK) Interaction between Rezafungin and Nine Probe Drugs: Results from a Drug-Drug Interaction (DDI) Study

被引：0
|
作者：
Ong, Voon [1 ]
Sandison, Taylor [1 ]
Flanagan, Shawn [1 ]
机构：
[1] Cidara Therapeut, San Diego, CA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
535
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Drug-Drug Interaction Potential of Mavacamten with Oral Contraceptives: Results from a Clinical Pharmacokinetic Study and a Physiologically Based Pharmacokinetic Model
    Chiang, Manting
    Sychterz, Caroline
    Gaohua, Lu
    Perera, Vidya
    Gretler, Daniel D.
    Florea, Victoria
    Merali, Samira
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (11): : 1275 - 1282
  • [42] Drug-drug interaction (DDI) potential of oral napabucasin in healthy adults
    Dai, Xiaoshu
    Karol, Michael D.
    Hitron, Matthew
    Hard, Marjie
    Goulet, Matthew T.
    Mclaughlin, Colleen F.
    Brantley, Scott J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [43] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING TO EVALUATE DRUG-DRUG INTERACTION (DDI) RISK OF ALECTINIB.
    Cleary, Y.
    Gertz, M.
    Morcos, P. N.
    Youdim, K.
    Fowler, S.
    Yu, L.
    Sekiguchi, N.
    Takanashi, K.
    Kaneko, A.
    Phipps, A.
    Parrott, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S40 - S40
  • [44] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR SIMULATION OF NALOXEGOL PHARMACOKINETICS AND DRUG-DRUG INTERACTION (DDI) POTENTIAL
    Zhou, D.
    Bui, K.
    Sostek, M.
    Al-Huniti, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S53 - S53
  • [45] Verapamil and pristimerin pharmacokinetic drug-drug interaction study in rats - perspectives
    Srinivas, Nuggehally R.
    BIOMEDICAL CHROMATOGRAPHY, 2016, 30 (12) : 2074 - 2074
  • [46] DRUG-DRUG INTERACTION WITH THE USE OF ANTIRHEUMATIC DRUGS
    ARNESON, HT
    COLTON, RS
    MINNESOTA MEDICINE, 1987, 70 (10) : 589 - &
  • [47] What is the true risk of a pharmacokinetic drug-drug interaction?
    Fuhr, Uwe
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (10) : 897 - 899
  • [48] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL (PBPK) TO PREDICT PH-DEPENDENT DRUG-DRUG INTERACTION (DDI) FORWEAK BASE DRUGS (WBDS)
    Dong, Z.
    Wu, F.
    Zhao, P.
    Lee, S. -C.
    Zhang, L.
    Seo, P.
    Zhang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S27 - S27
  • [49] Cenobamate/ClobazamFatigue following pharmacokinetic drug-drug interaction
    Reactions Weekly, 2024, 2008 (1) : 98 - 98
  • [50] Pharmacokinetic drug-drug interaction and their implication in clinical management
    Caterina, Palleria
    Antonello, Di Paolo
    Chiara, Giofre
    Chiara, Caglioti
    Giacomo, Leuzzi
    Antonio, Siniscalchi
    Giovambattista, De Sarro
    Luca, Gallelli
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2013, 18 (07): : 600 - 609
12345